Atherosclerotic Disease Update: A Chat with Dr. Manesh Patel
By DocWire News Editors - Last Updated: April 27, 2023Manesh R. Patel, MD, Professor of Medicine and Chief of Cardiology at Duke University School of Medicine, talks with DocWire News about the latest in atherosclerotic disease research focusing on CAD/PAD. Dr. Patel also sheds light on recent therapeutic options available for a variety of clinical scenarios, including statins, PCSK9 inhibitors, icosapent ethyl, and more.
Advertisement
To watch more DocWire News interviews with leading KOLs in this space and others, visit our YouTube channel. Follow us on Twitter (@mydocwire) and Facebook (@mydocwire).
Advertisement
Related Posts
Researchers have developed a polygenic risk score to analyze the link between dysfunctional endothelial and CAD.
This structural discovery is a step toward the development of next-generation therapies to modulate LDL.
The FDA recently announced a first time proposed rule which would require the tobacco industry to lower nicotine levels.
Researchers explored how immune checkpoint inhibitors interact with immune cells in arterial plaques.
A study found a comparable reduction in LDL-C with statins and bempedoic acid in patients with and without ASCVD.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.